Jacqueline Barry

Jacqueline Barry is a senior business leader with over 20 years of experience in biologics and advanced therapies. She is passionate about supporting the translation of advanced therapies and possesses a blend of expertise across the areas of regulation, quality, Good Manufacturing Practice, science, strategy, commercial development and management. Jacqueline holds an executive position at the Cell and Gene Therapy Catapult where she leads a team that is dedicated to developing regulatory and translational strategies for advanced therapy products, as well as working to ensure that the wider ecosystem supports the development and adoption of these therapies in the UK and beyond. She also leads a network of advanced therapy treatment centres in the UK that aim to accelerate patient access to these transformative therapies.